Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. COVID-19 transmission low in NSW education settings

    Publicly released: Tue 27 Oct 2020 at 0601 AEDT | 0801 NZDT

    The spread of COVID-19 remains extremely low in NSW schools and early childhood centres with onward transmission of less than 1 per cent in Term 3, a new report shows. Read more about COVID-19 transmission low in NSW education settings

    Australia; NSWNational Centre for Immunisation Research and Surveillance (NCIRS)
  2. People with preexisting issues may be at a higher risk of depression during COVID-times

    Publicly released: Tue 27 Oct 2020 at 0200 AEDT | 0400 NZDT

    JAMA Network Open

    The team says that people who had experienced physical or psychological abuse, had preexisting mental health issues or physical conditions, poor access to social support, and people living in low Read more about People with preexisting issues may be at a higher risk of depression during COVID-times

    InternationalUniversity College London, UK
  3. Partial immunity and social distancing could reduce COVID-19 mortality rates

    Publicly released: Mon 26 Oct 2020 at 1200 AEDT | 1400 NZDT

    mBio

    Partial immunity to SARS-CoV-2 combined with social distancing would significantly reduce mortality rates, new mathematical modelling shows. Read more about Partial immunity and social distancing could reduce COVID-19 mortality rates

    Australia; QLDGriffith University|University of Alberta, Canada
  4. Universal face masking could save almost 130,000 lives in US

    Publicly released: Sat 24 Oct 2020 at 0200 AEDT | 0400 NZDT

    Nature Medicine

    The researchers analysed the spread of the coronavirus from the first case to the end of September this year, and modelled different scenarios to see how non-pharmaceutical interventions like wearing Read more about Universal face masking could save almost 130,000 lives in US

    Australia; International; QLDThe University of Queensland|QIMR Berghofer Medical Research Institute...
  5. COVID-19 a double blow for chronic disease patients

    Publicly released: Fri 23 Oct 2020 at 1500 AEDT | 1700 NZDT

    Frontiers in Public Health

    The COVID-19 pandemic has escalated into a ‘syndemic’ for people with chronic illnesses, a new UNSW study analysing data from low and middle-income countries shows. ... factors – such as substance Read more about COVID-19 a double blow for chronic disease patients

    Australia; NSWThe University of New South Wales
  6. Around 3 in 4 Americans report hearing conflicting information about COVID-19

    Publicly released: Fri 23 Oct 2020 at 1100 AEDT | 1300 NZDT

    PLOS ONE

    Overall, participants noticed more disagreement among politicians than health  experts - and people perceived there to be more disagreement around specific aspects of COVID-19 than around the Read more about Around 3 in 4 Americans report hearing conflicting information about COVID-19

    InternationalUniversity of Minnesota, USA
  7. Combination of physical distancing measures can keep COVID at bay

    Publicly released: Fri 23 Oct 2020 at 0930 AEDT | 1130 NZDT

    The Lancet Infectious Diseases

    UK researchers have analysed 131 countries, including Australia and New Zealand, to determine the impact of physical distancing measures - such as work closures, caps on gatherings and public event Read more about Combination of physical distancing measures can keep COVID at bay

    Australia; New Zealand; InternationalUniversity of Edinburgh, UK
  8. Voters unlikely to decide whether to pick Trump, Boris or Modi based on their pandemic performance

    Publicly released: Fri 23 Oct 2020 at 0930 AEDT | 1130 NZDT

    BMJ Global Health

    Despite viewing their governments as responsible for the spread of COVID-19, voters in the US, UK and India are unlikely to punish or reward their leaders at the polls for ... Some people were told key Read more about Voters unlikely to decide whether to pick Trump, Boris or Modi based on their pandemic performance

    InternationalOxford University, UK, University of Texas at Austin. US
  9. COVID-19 risks higher for those with Down Syndrome

    Publicly released: Thu 22 Oct 2020 at 1600 AEDT | 1800 NZDT

    Annals of Internal Medicine

    The researchers analysed data from a study of 8. 26 million adults in the UK and say heart issues and care home living among those with Down Syndrome contributes some, but ... not all of the risk, and Read more about COVID-19 risks higher for those with Down Syndrome

    InternationalNuffield Department of Primary Care Health Sciences, UK
  10. COVID-19 vaccine trials not designed to show if they will save lives

    Publicly released: Thu 22 Oct 2020 at 0930 AEDT | 1130 NZDT

    The BMJ

    Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus. ... They argue there is still time to advocate for changes to ensure the ongoing trials address the Read more about COVID-19 vaccine trials not designed to show if they will save lives

    InternationalThe BMJ
  11. Arthritis drug tocilizumab shows no clear benefit for moderate COVID-19

    Publicly released: Thu 22 Oct 2020 at 0800 AEDT | 1000 NZDT

    New England Journal of Medicine

    The drug tocilizumab, which supresses the immune system and is used mainly for the treatment of rheumatoid arthritis, was not effective for preventing intubation or death in moderately-ill Read more about Arthritis drug tocilizumab shows no clear benefit for moderate COVID-19

    InternationalHarvard Medical School, USA
  12. Digital inclusion report warns of COVID impact

    Publicly released: Thu 22 Oct 2020 at 0600 AEDT | 0800 NZDT

    The 2020 Australian Digital Inclusion Index (ADII), published 22 October, shows that a high level of digital inequality persists in Australia with many groups continuing to miss out on the benefits Read more about Digital inclusion report warns of COVID impact

    Australia; VICRMIT University|Swinburne University of Technology
  13. NZ looks to Taiwan’s approach to the pandemic

    Publicly released: Wed 21 Oct 2020 at 2000 AEDT | 2200 NZDT

    The Lancet Regional Health - Western Pacific

    New Zealand and Taiwanese health researchers have swapped notes regarding how their respective countries have dealt with the COVID-19 pandemic. ... The researchers say Taiwan had extensive public health Read more about NZ looks to Taiwan’s approach to the pandemic

    New Zealand; InternationalUniversity of Otago
  14. EXPERT REACTION: Victoria reports case of COVID-19 reinfection

    Publicly released: Wed 21 Oct 2020 at 1230 AEDT | 1430 NZDT

    During a press conference, the Premier said a male patient first tested positive back in June, and following his more recent positive test, an expert panel reviewed his case and "concluded Read more about EXPERT REACTION: Victoria reports case of COVID-19 reinfection

    Australia; NSW; VIC; QLD; WA; ACTAustralian Science Media Centre|The Westmead Institute for Medical Research...
  15. New tool predicts who is at risk of dying from COVID-19

    Publicly released: Wed 21 Oct 2020 at 1001 AEDT | 1201 NZDT

    The BMJ

    The people in the top 20 per cent for predicted risk of death accounted for 94 per cent of Covid-19 deaths. ... Although QCOVID has been specifically designed for the UK it has international potential, Read more about New tool predicts who is at risk of dying from COVID-19

    InternationalUniversity of Oxford, UK
  16. Bound by infection: identifying how COVID-19 interacts with cells

    Publicly released: Wed 21 Oct 2020 at 1000 AEDT | 1200 NZDT

    Science

    Two international studies, including Australian researchers, have shed important light on why the virus that causes COVID-19 is so infectious compared to other SARS viruses. Read more about Bound by infection: identifying how COVID-19 interacts with cells

    Australia; QLDThe University of Queensland
  17. Automation, AI & the Cloud: Scoping transport and mobility sector jobs skills gaps and training needs

    Publicly released: Wed 21 Oct 2020 at 0830 AEDT | 1030 NZDT

    A new study aims to give state and federal policymakers a clear roadmap on filling the skills gaps in the wide-ranging transport and mobility sector, worth more than $123 billion ... the face of Read more about Automation, AI & the Cloud: Scoping transport and mobility sector jobs skills gaps and training needs

    AustraliaiMOVE Australia|RMIT University
  18. EXPERT REACTION: Is arthritis drug tocilizumab another treatment for COVID-19?

    Publicly released: Wed 21 Oct 2020 at 0400 AEDT | 0600 NZDT

    JAMA Internal Medicine

    Across a series of studies, international researchers have investigated whether tocilizumab, an immunosuppressive drug used mainly for the treatment of rheumatoid arthritis, is an effective Read more about EXPERT REACTION: Is arthritis drug tocilizumab another treatment for COVID-19?

    International; NSW; QLD; ACTBrigham and Women’s Hospital, US, Unita Operativa di Reumatologia in Reggio Emilia, Italy, Université de Paris, France
  19. An in-depth look at COVID-19's effects on the heart

    Publicly released: Tue 20 Oct 2020 at 0500 AEDT | 0700 NZDT

    Journal of the American College of Cardiology

    The second paper addresses the global concerns COVID-19 has raised for the health and safety of heart disease patients. ... The third and final paper looks at the damage COVID-19 causes to the heart, Read more about An in-depth look at COVID-19's effects on the heart

    InternationalCenter for Cardiovascular Health at Mount Sinai Heart, USA, University of Chicago, USA,
  20. EXPERT REACTION: WHO COVID-19 trial finds remdesivir, hydroxychloroquine, lopinavir and interferon don't save lives

    Publicly released: Fri 16 Oct 2020 at 1100 AEDT | 1300 NZDT

    medRxiv

    The World Health Organisation has published interim results of its Solidarity trial, which investigated whether remdesivir, hydroxychloroquine, lopinavir and interferon regimens were effective Read more about EXPERT REACTION: WHO COVID-19 trial finds remdesivir, hydroxychloroquine, lopinavir and interferon don't save lives

    International; NSW; VIC; QLD; SA; ACTWorld Health Organization

Show Results

  1. 10
  2. 20
  3. 50